Cargando…
The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort
Background and Objectives: Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis. Antibiotic prophylaxis is effective but can lead to an increased incidence of Clostridioides difficile infection (CDI). The aim of this study was to evaluate the incidence of CDI...
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464987/ https://www.ncbi.nlm.nih.gov/pubmed/34577887 http://dx.doi.org/10.3390/medicina57090964 |
_version_ | 1784572755706904576 |
---|---|
author | Girleanu, Irina Trifan, Anca Huiban, Laura Muzica, Cristina Nemteanu, Roxana Teodorescu, Andreea Singeap, Ana Maria Cojocariu, Camelia Chiriac, Stefan Petrea, Oana Zenovia, Sebastian Nastasa, Robert Cuciureanu, Tudor Stanciu, Carol |
author_facet | Girleanu, Irina Trifan, Anca Huiban, Laura Muzica, Cristina Nemteanu, Roxana Teodorescu, Andreea Singeap, Ana Maria Cojocariu, Camelia Chiriac, Stefan Petrea, Oana Zenovia, Sebastian Nastasa, Robert Cuciureanu, Tudor Stanciu, Carol |
author_sort | Girleanu, Irina |
collection | PubMed |
description | Background and Objectives: Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis. Antibiotic prophylaxis is effective but can lead to an increased incidence of Clostridioides difficile infection (CDI). The aim of this study was to evaluate the incidence of CDI and the risk factors in cirrhotic patients with a previous episode of SBP receiving norfloxacin as secondary prophylaxis. Materials and Methods: We performed a prospective, cohort study including patients with liver cirrhosis and SBP, successfully treated over a 2-year period in a tertiary university hospital. All the patients received secondary prophylaxis for SBP with norfloxacin 400 mg/day. Results: There were 122 patients with liver cirrhosis and SBP included (mean age 57.5 ± 10.8 years, 65.5% males). Alcoholic cirrhosis was the major etiology accounting for 63.1% of cases. The mean MELD score was 19.7 ± 6.1. Twenty-three (18.8%) of all patients developed CDI during follow-up, corresponding to an incidence of 24.8 cases per 10,000 person-years. The multivariate Cox regression analysis demonstrated that alcoholic LC etiology (HR 1.40, 95% CI 1.104–2.441, p = 0.029) and Child-Pugh C class (HR 2.50, 95% CI 1.257–3.850, p = 0.034) were independent risk factors for CDI development during norfloxacin secondary prophylaxis. The development of CDI did not influence the mortality rates in cirrhotic patients with SBP receiving norfloxacin. Conclusions: Cirrhotic patients with SBP and Child-Pugh C class and alcoholic liver cirrhosis had a higher risk of developing Clostridioides difficile infection during norfloxacin secondary prophylaxis. In patients with alcoholic Child-Pugh C class liver cirrhosis, alternative prophylaxis should be evaluated as SBP secondary prophylaxis. |
format | Online Article Text |
id | pubmed-8464987 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-84649872021-09-27 The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort Girleanu, Irina Trifan, Anca Huiban, Laura Muzica, Cristina Nemteanu, Roxana Teodorescu, Andreea Singeap, Ana Maria Cojocariu, Camelia Chiriac, Stefan Petrea, Oana Zenovia, Sebastian Nastasa, Robert Cuciureanu, Tudor Stanciu, Carol Medicina (Kaunas) Article Background and Objectives: Spontaneous bacterial peritonitis (SBP) is a life-threatening complication of liver cirrhosis. Antibiotic prophylaxis is effective but can lead to an increased incidence of Clostridioides difficile infection (CDI). The aim of this study was to evaluate the incidence of CDI and the risk factors in cirrhotic patients with a previous episode of SBP receiving norfloxacin as secondary prophylaxis. Materials and Methods: We performed a prospective, cohort study including patients with liver cirrhosis and SBP, successfully treated over a 2-year period in a tertiary university hospital. All the patients received secondary prophylaxis for SBP with norfloxacin 400 mg/day. Results: There were 122 patients with liver cirrhosis and SBP included (mean age 57.5 ± 10.8 years, 65.5% males). Alcoholic cirrhosis was the major etiology accounting for 63.1% of cases. The mean MELD score was 19.7 ± 6.1. Twenty-three (18.8%) of all patients developed CDI during follow-up, corresponding to an incidence of 24.8 cases per 10,000 person-years. The multivariate Cox regression analysis demonstrated that alcoholic LC etiology (HR 1.40, 95% CI 1.104–2.441, p = 0.029) and Child-Pugh C class (HR 2.50, 95% CI 1.257–3.850, p = 0.034) were independent risk factors for CDI development during norfloxacin secondary prophylaxis. The development of CDI did not influence the mortality rates in cirrhotic patients with SBP receiving norfloxacin. Conclusions: Cirrhotic patients with SBP and Child-Pugh C class and alcoholic liver cirrhosis had a higher risk of developing Clostridioides difficile infection during norfloxacin secondary prophylaxis. In patients with alcoholic Child-Pugh C class liver cirrhosis, alternative prophylaxis should be evaluated as SBP secondary prophylaxis. MDPI 2021-09-13 /pmc/articles/PMC8464987/ /pubmed/34577887 http://dx.doi.org/10.3390/medicina57090964 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Girleanu, Irina Trifan, Anca Huiban, Laura Muzica, Cristina Nemteanu, Roxana Teodorescu, Andreea Singeap, Ana Maria Cojocariu, Camelia Chiriac, Stefan Petrea, Oana Zenovia, Sebastian Nastasa, Robert Cuciureanu, Tudor Stanciu, Carol The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title | The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title_full | The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title_fullStr | The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title_full_unstemmed | The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title_short | The Risk of Clostridioides difficile Infection in Cirrhotic Patients Receiving Norfloxacin for Secondary Prophylaxis of Spontaneous Bacterial Peritonitis—A Real Life Cohort |
title_sort | risk of clostridioides difficile infection in cirrhotic patients receiving norfloxacin for secondary prophylaxis of spontaneous bacterial peritonitis—a real life cohort |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8464987/ https://www.ncbi.nlm.nih.gov/pubmed/34577887 http://dx.doi.org/10.3390/medicina57090964 |
work_keys_str_mv | AT girleanuirina theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT trifananca theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT huibanlaura theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT muzicacristina theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT nemteanuroxana theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT teodorescuandreea theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT singeapanamaria theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT cojocariucamelia theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT chiriacstefan theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT petreaoana theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT zenoviasebastian theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT nastasarobert theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT cuciureanutudor theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT stanciucarol theriskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT girleanuirina riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT trifananca riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT huibanlaura riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT muzicacristina riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT nemteanuroxana riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT teodorescuandreea riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT singeapanamaria riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT cojocariucamelia riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT chiriacstefan riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT petreaoana riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT zenoviasebastian riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT nastasarobert riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT cuciureanutudor riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort AT stanciucarol riskofclostridioidesdifficileinfectionincirrhoticpatientsreceivingnorfloxacinforsecondaryprophylaxisofspontaneousbacterialperitonitisareallifecohort |